Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration
- PMID: 27654856
- PMCID: PMC5031982
- DOI: 10.1038/srep33830
Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration
Erratum in
-
Corrigendum: Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration.Sci Rep. 2017 Jan 19;7:40460. doi: 10.1038/srep40460. Sci Rep. 2017. PMID: 28102236 Free PMC article. No abstract available.
Abstract
Mutations in optineurin (OPTN) are linked to the pathology of primary open angle glaucoma (POAG) and amyotrophic lateral sclerosis. Emerging evidence indicates that OPTN mutation is involved in accumulation of damaged mitochondria and defective mitophagy. Nevertheless, the role played by an OPTN E50K mutation in the pathogenic mitochondrial mechanism that underlies retinal ganglion cell (RGC) degeneration in POAG remains unknown. We show here that E50K expression induces mitochondrial fission-mediated mitochondrial degradation and mitophagy in the axons of the glial lamina of aged E50K-tg mice in vivo. While E50K activates the Bax pathway and oxidative stress, and triggers dynamics alteration-mediated mitochondrial degradation and mitophagy in RGC somas in vitro, it does not affect transport dynamics and fission of mitochondria in RGC axons in vitro. These results strongly suggest that E50K is associated with mitochondrial dysfunction in RGC degeneration in synergy with environmental factors such as aging and/or oxidative stress.
Figures
References
-
- Weinreb R. N. & Khaw P. T. Primary open-angle glaucoma. Lancet 363, 1711–1720 (2004). - PubMed
-
- Zhang K., Zhang L. & Weinreb R. N. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov 11, 541–559 (2012). - PubMed
-
- Maruyama H. et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223–226 (2010). - PubMed
-
- Rezaie T. et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077–1079 (2002). - PubMed
-
- Kroeber M., Ohlmann A., Russell P. & Tamm E. R. Transgenic studies on the role of optineurin in the mouse eye. Experimental Eye Research 82, 1075–1085 (2006). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
